1.1.Kong D, Lee MJ,Lin S*, Kim ES*. Biosynthesis and pathway engineering of antifungal polyene macrolides inactinomycetes.J Ind Microbiol Biotechnol,2013, 40(6):529-43.
2.2.Lin S, Huang T, Shen B*. Tailoring enzymes acting on carrier protein-tethered substrates in natural product biosynthesis.Methods Enzymol,2012, 516:321-43.
3.3.Lin S, Huang T, Horsman GP, Huang SX, Guo X, Shen B*. Specificity of the ester bond forming condensation enzyme SgcC5 in C-1027 biosynthesis.Org Lett, 2012, 14(9):2300-3.
4.4.Lin S, Horsman GP, Shen B*. Characterization of the epoxide hydrolase NcsF2 from the neocarzinostatin biosynthetic gene cluster.Org Lett,2010, 12(17):3816-3819.
5.5.Lin S, Van Lanen SG and Shen B*. A free-standing condensation enzyme catalyzing ester bond formation in C-1027 biosynthesis.Proc. Natl. Acad. Sci. U.S.A, 2009, 106(11):4183-4188.
7.7.Lin S, Van Lanen SG, Shen B*.Characterization of the two-component, FAD-dependent monooxygenase SgcC that requires carrier protein-tethered substrates for the biosynthesis of the enediyne antitumor antibiotic C-1027.J Am Chem Soc, 2008, 130(20):6616-6623.
8.8.Van Lanen SG,Lin S, Shen B*. Biosynthesis of the enediyne antitumor antibiotic C-1027 involves a new branching point in chorismate metabolism.Proc. Natl. Acad. Sci. U.S.A, 2008, 105(2):494-499.
9.9.Lin S, Van Lanen SG, Shen B*. Regiospecific chlorination of (S)-beta-tyrosyl-S-carrier protein catalyzed by SgcC3 in the biosynthesis of the enediyne antitumor antibiotic C-1027.J Am Chem Soc,2007, 129(41):12432-12438.